Skip to main content
logo
Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
31.37
+0.82 (2.68%)
At close: Jun 4, 2026, 4:00 PM EDT
30.87
-0.50 (-1.59%)
After-hours: Jun 4, 2026, 4:17 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
GPCR Oral Small Molecule Drug Discovery
45.95M1.08M151.00K
GPCR Oral Small Molecule Drug Discovery Growth
4174.51%611.92%-
Total
45.95M1.08M151.00K
Total Growth
4174.51%611.92%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
United States
45.95M1.08M151.00K
United States Growth
4174.51%611.92%-
Total
45.95M1.08M151.00K
Total Growth
4174.51%611.92%-
Source: S&P Global Market Intelligence.